Login
← Go Back
Hikal
HIKAL · Pharma > Pharmaceuticals & Drugs · Chairman: Jai Hiremath · MD: Jai Hiremath · Listing date: Feb. 15, 2001 · Employees: 1528 · Navi Mumbai · http://www.hikal.com
Stock Price vs Company Growth
1d
0.1%
1w
6.8%
1m
3.2%
3m
14.5%
6m
20.2%
1y
48.5%
5y
16.1%
10y
6.5%
all
8.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 190 0.1%
146
228
Company Overview
Sales
1,713 Cr
Growth: -3.0%
Profit after Tax
-48.8 Cr
Growth: 275.4%
Small Cap
2,344 Cr
P/S: 1.4x
Industry P/S: 2.6x
Fundamentals
Sales (Cr) ₹ 1,713
Growth -3.0%
EBITDA 12.9%
P/S 1.4x
Dividend 0.4%
P/E -48.0x
Book Value ₹ 97.2
PEG Ratio 15.8x
ROE -4.0%
P/B 1.9x
Shareholding Pattern
Institutions
Government Pension Fund Global
2.31 %
Promoters
Kalyani Investment Company Limited
31.36 %
Shri Badrinath Investment Pvt Ltd
16.15 %
Shri Rameshwara Investment Pvt Ltd
7.96 %
Sugandha Jai Hiremath
7.84 %
Bf Investment Limited
2.65 %
Others
Si Investments And Broking Private Limited
1.62 %
Llp
0.4 %
Iepf
0.21 %
Increase    Decrease    No change
Company Profile Detailed
Established in 1988 Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner. Their advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA. Hikal is a company built on enduring relationships.
Belongs to (8 Indices) view more
Investors (64)
sugandha...
ashok.vi...
idfc.ste...
Followers (6)
mike2
nitin29
vishal48